Stock Events

Stock Events

Ventripoint Diagnostics 

€0.065500
22
-€0.00-3.68% Thursday 06:03

Statistics

Day High
0.0655
Day Low
0.0655
52W High
0.094
52W Low
0.0625
Volume
0
Avg. Volume
195
Mkt Cap
11.08M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Financials

-1,784.12%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
112,340.05Revenue
-2MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 5V7.MU. It's not an investment recommendation.
iShares Core Equity Portfolio
5
XEQT.TO
NVIDIA
4
NVDA
Palantir Technologies
4
PLTR
Taiwan Semiconductor Manufacturing
4
TSM

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
GE Aerospace
GE
Mkt Cap355.45B
General Electric, through its healthcare division, offers advanced imaging and diagnostic technologies that compete with Ventripoint's heart analysis systems.
Koninklijke Philips N.V.
PHG
Mkt Cap26.12B
Philips, a leading health technology company, provides a range of diagnostic imaging technologies, including ultrasound, which competes with Ventripoint's cardiac analysis solutions.
Siemens
SIEGY
Mkt Cap239.92B
Siemens Healthineers offers a comprehensive portfolio of diagnostic imaging and laboratory diagnostics equipment, directly competing with Ventripoint's diagnostic solutions.
Thermo Fisher Scientific
TMO
Mkt Cap230.05B
Thermo Fisher Scientific provides a variety of analytical instruments, including imaging technologies, that serve the same market as Ventripoint's diagnostic products.
Abbott Laboratories
ABT
Mkt Cap194.62B
Abbott Laboratories offers a wide range of diagnostic solutions, including cardiac imaging technologies that compete with Ventripoint's offerings.
Medtronic
MDT
Mkt Cap116.77B
Medtronic provides medical devices and technology, including cardiac diagnostic and monitoring tools, that compete with Ventripoint's heart analysis systems.
Boston Scientific
BSX
Mkt Cap67.88B
Boston Scientific specializes in medical devices that include cardiovascular diagnostic and therapeutic products, competing with Ventripoint's technologies.
Intuitive Surgical
ISRG
Mkt Cap131.63B
Intuitive Surgical, known for its robotic-assisted surgical systems, also delves into diagnostic imaging, indirectly competing with Ventripoint's diagnostic imaging solutions.
Baxter International
BAX
Mkt Cap13.51B
Baxter International offers a range of medical devices and laboratory equipment that, while not directly competing in cardiac diagnostics, serves the broader diagnostic market alongside Ventripoint.

About

VentriPoint Diagnostics Ltd. (VPTDF) is a medical technology company dedicated to creating and bringing to market diagnostic tools for the global assessment of patients with cardiac conditions. The company's primary offering is the VentriPoint Medical System (VMS), an advanced medical imaging platform. This system, utilizing its VMS+ software, constructs precise three-dimensional representations of a patient's heart chambers by processing echocardiogram and magnetic resonance imaging (MRI) data. It is designed to yield consistent and accurate volumetric and functional measurements, including ejection fraction. Additionally, VentriPoint is actively developing a suite of specialized applications to address a broad spectrum of heart diseases and diverse imaging techniques. This portfolio includes solutions for conditions such as congenital heart defects, pulmonary hypertension, cardiotoxicity observed in oncology patients, and cardiac complications stemming from COVID-19. Established in 2004, the company's headquarters are located in Toronto, Canada.
Show more...
CEO
Hugh MacNaught
Employees
3
Country
Canada
ISIN
CA92281P2008
WKN
000A2ABKZ

Listings

MU
DE
5V7.MU
OTC Link
US
VPTDF
F
DE
5V7.F
V
CA
VPT.V

0 Comments

Share your thoughts

FAQ

What is Ventripoint Diagnostics stock price today?▼
The current price of 5V7.MU is €0.07 EUR — it has decreased by -3.68% in the past 24 hours. Watch Ventripoint Diagnostics stock price performance more closely on the chart.
What is Ventripoint Diagnostics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange Ventripoint Diagnostics stocks are traded under the ticker 5V7.MU.
Is Ventripoint Diagnostics stock price growing?▼
5V7.MU stock has fallen by -5.07% compared to the previous week, the month change is a -16.56% fall, over the last year Ventripoint Diagnostics has showed a -15.48% decrease.
What is Ventripoint Diagnostics market cap?▼
Today Ventripoint Diagnostics has the market capitalization of 11.08M
What is Ventripoint Diagnostics revenue for the last year?▼
Ventripoint Diagnostics revenue for the last year amounts to 112,340.05 EUR.
What is Ventripoint Diagnostics net income for the last year?▼
5V7.MU net income for the last year is -2M EUR.
How many employees does Ventripoint Diagnostics have?▼
As of September 04, 2026, the company has 3 employees.
In which sector is Ventripoint Diagnostics located?▼
Ventripoint Diagnostics operates in the Health & Wellness sector.
When did Ventripoint Diagnostics complete a stock split?▼
The last stock split for Ventripoint Diagnostics was on December 07, 2015 with a ratio of 1:10.
Where is Ventripoint Diagnostics headquartered?▼
Ventripoint Diagnostics is headquartered in Toronto, Canada.